Epitranscriptome refers to post-transcriptional modifications to RNA and their associated regulatory factors that can govern changes in an organism’s cells in response to various environmental stimuli. Recent studies have recognized over 170 distinct chemical signatures in RNA, and the list keeps expanding. These modifications are hypothesized to have roles beyond simply fine-tuning the structure and function of RNA, as studies have linked them to various infectious and noninfectious diseases in humans. Dedicated cellular machinery comprising of RNA-binding proteins (RBPs) that can write, erase, and read these modifications drives the regulation of the epitranscriptomic code, and as such influences RNA metabolism and homeostasis. Equally, perturbations in the function of RBPs may disrupt RNA processing, further implicating them in pathogenesis. As such, the mechanisms underlying RNA modifications and their association with RBPs are emerging areas of interest within the field of biomedicine. This review focuses on understanding epitranscriptomic modifications, their effects on RNA–RBPs interactions, and their influence on cellular processes.
27 February 2026 in International Forum of Allergy & Rhinology
Background: Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disorder frequently associated with impaired mucociliary clearance and bacterial infection. Individuals carrying a single cystic fibrosis transmembrane conductance regulator (CFTR) mutation exhibit partial CFTR dysfunction and are increasingly recognized as being at risk for CRS; however, the sinonasal phenotype and host–pathogen interactions in CF carriers remain poorly defined. Methods: We characterized heterozygous ΔF508 CF rabbits (heterozygous, n = 6) compared with wild‐type (WT) ( n = 5). Baseline sinonasal structure was assessed by computed tomography and histology. CFTR function was measured by nasal potential difference (NPD) and Ussing chamber analysis of primary epithelial cultures, with or without CFTR modulators. Bacterial sinusitis was induced using Pseudomonas aeruginosa (PA14), followed by longitudinal imaging, bacterial quantification, histology, and PA14 RNA sequencing. Results: Heterozygous rabbits demonstrated significant sinus hypoplasia compared with WT (mm 3 : heterozygous 77.9 vs. WT 108.1 mm 3 , p < 0.01) without spontaneous sinusitis. NPD revealed ∼50% reduction in chloride transport relative to WT (∆mV: heterozygous −15.5 vs. WT −35.8, p < 0.01). CFTR modulation partially restored chloride secretion in epithelial cells from heterozygous to ∼80% of WT ( p < 0.0001). Following P. aeruginosa inoculation, heterozygous rabbits exhibited higher bacterial burden ( p < 0.05), persistent radiographic opacification (week 4, p < 0.01), and delayed histologic recovery. PA14 RNAseq revealed a distinct transcriptional profile in the heterozygous sinonasal environment. Conclusions: Heterozygous ΔF508 CF rabbits recapitulate key sinonasal features relevant to CF carriers, including reduced CFTR function, altered host defense, and impaired infection clearance. This model provides a translational platform for investigating CRS pathogenesis and evaluating CFTR‐targeted therapies in CF carriers.